Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens' (WBA) recent deal with Abbott is part of its ongoing efforts to offer greater testing access, helping reduce the spread of COVID-19 and improve the health of communities.

Walgreens (WBA) Inks Deal to Expand COVID-19 Testing Access

DEERFIELD, Ill.--(BUSINESS WIRE)--Beginning this week, Walgreens will sell Abbott's BinaxNOW™ Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide.

Walgreens Makes Abbott's BinaxNOW™ COVID-19 Self Test Available Over-The-Counter at Stores Nationwide

Apple

Amgen

Caterpillar

Salesforce

Cisco Systems

Chevron

East West Bancorp

IAMGOLD

JPMorgan Chase & Co

Microsoft

Bancorp

Two new breakout stocks for Week 16 of 2021 with better than 10% short-term upside potential. This past week 1 of 4 stocks beat 10% in less than 5 days with CTRN peaking at +14.1% and closing at 10.2%. The 2 Dow picks were mixed.

Week 16 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

Home Depot

National Retail Properties

Realty Income Corp

Walmart

W. P. Carey

Most investors are today heavily betting on the hot sectors of the moment: Tech stocks, SPACs, or even Bitcoin. I do the opposite in that I invest heavily in sectors that are currently overlooked and underappreciated by most investors.

I Put 1/4 Of My Net Worth Into These Investments

Walgreens (WBA) continues to expand access to COVID-19 vaccination in medically underserved communities and has surpassed 11 million administrations to date.

Walgreens (WBA) Extends COVID-19 Vaccination to 49 States

PayPal

Uber

Three heavy hitters in different verticals have announced a program aimed at increasing access to vaccines. On Monday (April 12), Walgreens, Uber and PayPal stated that they had donated a combined total of $11 million to the Vaccine Access Fund, which is to be used to give people in underserved communities free rides to Walgreens […]

Pandemic Partnership: Uber, Walgreens And PayPal Unite Over Vaccine Distribution

Uber, PayPal and Walgreens have launched a coalition to help people without transportation connect to COVID-19 vaccines, the companies announced Monday (April 12) in a press release. The three firms are together seeding the Vaccine Access Fund with $11 million to help people in underserved communities get to vaccination sites.

Uber, PayPal, Walgreens Team To Connect People With Vaccines

PayPal Holdings Inc (NASDAQ: PYPL), Uber Technologies Inc (NYSE: UBER), and Walgreens Boots Alliance Inc (NASDAQ: WBA) launched a new Vaccine Access Fund for vaccine access effort donations to connect underserved communities and people lacking transportation to COVID-19 vaccination sites. Additionally, customers can donate to the Vaccine Access Fund directly through the Uber app under a new donate feature braced by PayPal Giving Fund.

Uber, PayPal, and Walgreens Roll Out Vaccine Access Fund For Underserved Communities

Uber Technologies Inc, PayPal Holdings Inc and Walgreens Inc on Monday said they launched an $11 million fund to provide free ride-hail trips to U.S. COVID-19 vaccination sites for people who lack access to transportation.

Uber, PayPal, Walgreens launch $11 million vaccine rides fund

SAN JOSE, Calif., April 12, 2021 /PRNewswire/ -- Today, PayPal Holdings, Inc. (NASDAQ: PYPL), Uber Technologies, Inc. (NYSE: UBER) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) launched their new Vaccine Access Fund that allows customers to donate to vaccine access efforts to help connect people without transportation to COVID-19 vaccination sites, particularly those in underserved communities.

Uber, PayPal and Walgreens Introduce Vaccine Access Fund

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is now administering COVID-19 vaccines at a majority of its stores in 49 states, Washington, D.C. and Puerto Rico, as the company continues to play an integral role in the nation's vaccination and pandemic response efforts. With the initiative to vaccinate residents and staff in long-term care facilities nearly complete, close to 60,000 immunizers are now administering vaccinations at more than 7,000 Walgreens stores and through off-site clinics. The

Walgreens Now Administering COVID-19 Vaccinations in 49 States, Washington, D.C. and Puerto Rico

Walgreens has expanded its Covid-19 vaccination efforts to more than 7,000 stores in 49 states, Washington D. C. and Puerto Rico.

Walgreens Expands Covid-19 Vaccines To 49 States

The pharmacy giant is doubling down on its strengths and paying investors to wait for its transformation.

Should Investors Bail on Walgreens Stock?

Citi Trends

Liquidity Services

UnitedHealth Group

Two new breakout stocks for Week 15 of 2021 with better than 10% short-term upside potential. This past week 2 of 4 stocks beat 10% in less than 5 days with CAMT peaking at +10.3% and HIMX +15.7%. The 2 Dow picks gained over +6.7%.

Week 15 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

The shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) have received a price target increase from $50 to $60 by Citigroup. These are the details.

WBA Stock: $60 Target (Up From $50) By Citi

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance announces the commencement of cash tender offers for up to $2,750,000,000 aggregate principal amount of certain senior notes.

Walgreens Boots Alliance Commences Tender Offer to Purchase Certain Outstanding Debt Securities

Walgreens Boots Alliance saw the pandemic elevate the importance of entrepreneurial thinking blending with corporate social responsibility. I sat down with Annie Murphy at Walgreens Boots Alliance to talk about their approach and the issues that are top of mind for the business.

How Walgreens Boots Alliance Is Embracing An Entrepreneurial Mindset

VillageMD is considering an initial public offering in what could be the latest primary care provider to become publicly-traded to boost its expansion efforts.

Walgreens-Backed VillageMD Could Be Latest Primary Care IPO

Franklin Resources

Cincinnati Financial

Colgate-Palmolive

Clorox

Con Ed

Federal Realty Investment Trust

Genuine Parts

Johnson & Johnson

Coca-Cola

Leggett & Platt

Altria

National Fuel Gas

Northwest Natural Gas

Old Republic International

Procter & Gamble

SJW Group

Telephone and Data Systems

United Bankshares

Universal Corp

V.F.

Drip Investing lists over 800 stocks that have annually increased dividends for 5 years or more. These 66 stocks boosting 40 years and more were parsed from 139 Champions posted 3/31/21. The 66 ranged from 0.76% to 6.71% in annual yield and -15.85% to 25.10% in annual price target upside estimates per brokers sampled 4/5/21.

40-Year-Plus Annual Dividend Boosters For April Are 66

DEERFIELD, Ill.--(BUSINESS WIRE)--For the seventh year in a row, Red Nose Day is back at Walgreens with the iconic Red Nose in digital form as we continue to emphasize the health and safety of customers and team members nationwide. Driven by the COVID-19 pandemic, child poverty rose as high as 21.4 percent in the United States in 20201, underscoring the urgency to support underserved children. This year, together with Comic Relief U.S., the nonprofit behind Red Nose Day, Walgreens is excited to

Walgreens and Red Nose Day Bring Back Digital Red Nose, Spreading Message of Hope, Helping to Tackle Child Poverty

American Express

Ideanomics Inc

Ribbon Communications

Two new breakout stocks for Week 14 of 2021 with better than 10% short-term upside potential. This past week FBRX gained over 10% peaking at +14.7%. GNUS also spiked higher before bad reactions to an unclear Marvel deal spiraled into -29% decline.

Week 14 MDA Breakout Stocks - April 2021: Short-Term Picks To Give You An Edge

Merck

The nearly 125-year-old Dow Jones is home to three superb bargains.

The 3 Best Dow Stocks to Buy for the Second Quarter (and Beyond)

Walgreens stock has made serious gains in the first quarter of 2021, but there's still plenty of room for this pharmacy-led retail stock to climb higher. The post Best Stocks For 2021: Walgreens Boots Alliance (WBA) Just Went From Seriously Undervalued to Still Undervalued appeared first on InvestorPlace.

Best Stocks For 2021: Walgreens Boots Alliance (WBA) Just Went From Seriously Undervalued to Still Undervalued

Academy Sports and Outdoors

BioNTech SE

Chewy

Micron Technology

Out of a limited number of earnings reports released in this shortened week, we'll recap here the impact of the week's five best reports.

News for Walgreens Stock (WBA)